Lovastatin for the treatment of adult patients with dengue: A randomized, double-blind, placebo-controlled trial.

Lovastatin for the treatment of adult patients with dengue: A randomized, double-blind, placebo-controlled trial.

<h4>Background</h4> <p>Dengue endangers billions of people in the tropical world, yet no therapeutic is currently available. In part, the severe manifestations of dengue reflect inflammatory processes affecting the vascular endothelium. In addition to lipid lowering, statins have p...

Full description

Bibliographic Details
Main Authors:	Whitehorn, J, Nguyen, C, Khanh, L, Kien, D, Quyen, N, Tran, N, Hang, N, Truong, N, Hue Tai, L, Cam Huong, N, Nhon, V, Van Tram, T, Farrar, J, Wolbers, M, Simmons, C, Wills, B
Format:	Journal article
Language:	English
Published:	Oxford University Press 2016

Similar Items

Lovastatin for adult patients with dengue: protocol for a randomised controlled trial.
by: Whitehorn, J, et al.
Published: (2012)

Lovastatin for adult patients with dengue: protocol for a randomised controlled trial
by: Whitehorn, J, et al.
Published: (2012)

Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial
by: Tam, D, et al.
Published: (2012)

An evaluation of dried blood spots and oral swabs as alternative specimens for the diagnosis of dengue and screening for past dengue virus exposure.
by: Anders, K, et al.
Published: (2012)

An evaluation of dried blood spots and oral swabs as alternative specimens for the diagnosis of dengue and screening for past dengue virus exposure
by: Anders, K, et al.
Published: (2012)

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial.
by: Solomon, T, et al.
Published: (2003)

A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients.
by: Nguyen, N, et al.
Published: (2013)

A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients
by: Nguyen, N, et al.
Published: (2012)

Genetic variants of MICB and PLCE1 and associations with non-severe dengue.
by: Whitehorn, J, et al.
Published: (2013)

Genetic variants of MICB and PLCE1 and associations with non-severe dengue
by: Whitehorn, J, et al.
Published: (2013)

Genetic variants of MICB and PLCE1 and associations with the laboratory features of dengue
by: Whitehorn, J, et al.
Published: (2017)

CURRENT CONCEPTS Dengue
by: Simmons, C, et al.
Published: (2012)

Households as foci for dengue transmission in highly urban Vietnam.
by: Anders, K, et al.
Published: (2015)

Comparative susceptibility of Aedes albopictus and Aedes aegypti to dengue virus infection after feeding on blood of viremic humans: Implications for public health
by: Whitehorn, J, et al.
Published: (2015)

Sensitivity and specificity of a novel classifier for the early diagnosis of dengue.
by: Tuan, N, et al.
Published: (2015)

Methods to discriminate primary from secondary dengue during acute symptomatic infection
by: Tien, N, et al.
Published: (2018)

Dengue REPLY
by: Chau, N, et al.
Published: (2012)

Dengue.
by: Simmons, C, et al.
Published: (2012)

A29 Wolbachia for dengue control; will dengue viruses evolve resistance?
by: Vi, T, et al.
Published: (2017)

Dengue.
by: Whitehorn, J, et al.
Published: (2010)

A Prognostic Model for Development of Profound Shock among Children Presenting with Dengue Shock Syndrome
by: Lam, P, et al.
Published: (2015)

Production of Lovastatin by Penicillium spp. Soil Microfungi
by: Seydametova, Emine, et al.
Published: (2012)

Chikungunya and Zika virus cases detected against a backdrop of endemic dengue transmission in Vietnam
by: Quyen, N, et al.
Published: (2017)

Fluid resuscitation for dengue shock syndrome - The evidence from formal randomised and blinded intervention trials in Vietnam
by: Wills, B, et al.
Published: (2005)

The pathogenesis of dengue
by: Whitehorn, J, et al.
Published: (2011)

The pathogenesis of dengue.
by: Whitehorn, J, et al.
Published: (2011)

The pathogenesis of dengue
by: Whitehorn, J, et al.
Published: (2011)

Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials.
by: Simmons, C, et al.
Published: (2012)

Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials
by: Simmons, C, et al.
Published: (2012)

A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults
by: Mai, N, et al.
Published: (2018)

Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status.
by: Duyen, H, et al.
Published: (2011)

Kinetics of Plasma Viremia and Soluble Nonstructural Protein 1 Concentrations in Dengue: Differential Effects According to Serotype and Immune Status
by: Duyen, H, et al.
Published: (2011)

Current Concepts: Dengue
by: Simmons, C, et al.
Published: (2012)

A double blind, randomized, placebo-controlled trial of Lactobacillus acidophilus for the treatment of acute watery diarrhea in Vietnamese children.
by: Hong Chau, T, et al.
Published: (2017)

Modelling virus and antibody dynamics during dengue virus infection suggests a role for antibody in virus clearance
by: Clapham, H, et al.
Published: (2016)

Fluid solutions in dengue shock syndrome - Reply
by: Wills, B, et al.
Published: (2005)

Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam.
by: Anders, K, et al.
Published: (2011)

Dengue shock syndrome in children: clinical features and a prognostic model for profound shock
by: Lam, P, et al.
Published: (2013)

Assessment of microalbuminuria for early diagnosis and risk prediction in dengue infections
by: Tien, N, et al.
Published: (2013)

Association of microvascular function and endothelial biomarkers with clinical outcome in dengue: an observational study
by: Yacoub, S, et al.
Published: (2016)